抄録
1. Urinary excretion of S35 from the propylmercapto group after subcutaneous, intravenous or oral administration of TPD-S35(outer) was studied and S35 was shown to be excreted in the urine in large quantities (about 70% on the first day).
2. The majority of S35 was excreted in the urine in the form of sulfate after administration of TPD-S35(inner).
3. When TPD-S35(inner) was given intravenously, urinary excretion of thiamine was delayed compared with that in the case of thiamine-S35 and prolonged retention in the body was noted.
4. With oral administration of TPD-S35(inner), urinary excretion of thiamine was far greater than that in the case of thiamine-S35.
5. Urinary metabolites after administration of TPD-S35(inner) and thiamine-S35 in rabbits were examined and no compounds other than thiamine was detected.